Clinical Trials Logo

Clinical Trial Summary

The clinical study aims to compare the effectiveness of applying two different regimens of scorpion antivenom therapy. In the first regimen (control), the medication is administered to all patients, and depending on the severity of the condition, the dosage varies. In the experimental regimen, an identical dose of scorpion antivenom is administered to patients exhibiting signs and symptoms of scorpion sting intoxication, in addition to pain and other symptoms at the sting site. The primary response variable is the time taken for signs and symptoms to resolve, but differences in complications, adverse effects, venom and antivenom concentration in the blood, and the need for other therapeutic measures are also evaluated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06333834
Study type Interventional
Source University of Guadalajara
Contact Héctor A González-Ruiz, PhD student
Phone +52 33 1787 9139
Email andresgonzru@gmail.com
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date June 15, 2024
Completion date August 30, 2024